134 related articles for article (PubMed ID: 1968062)
1. Differential processing and turnover of the oncogenically activated neu/erb B2 gene product and its normal cellular counterpart.
Huang SS; Koh HA; Konish Y; Bullock LD; Huang JS
J Biol Chem; 1990 Feb; 265(6):3340-6. PubMed ID: 1968062
[TBL] [Abstract][Full Text] [Related]
2. Intracellular turnover, novel secretion, and mitogenically active intracellular forms of v-sis gene product in simian sarcoma virus-transformed cells. Implications for intracellular loop autocrine transformation.
Lokeshwar VB; Huang SS; Huang JS
J Biol Chem; 1990 Jan; 265(3):1665-75. PubMed ID: 2153139
[TBL] [Abstract][Full Text] [Related]
3. Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo.
Stern DF; Kamps MP; Cao H
Mol Cell Biol; 1988 Sep; 8(9):3969-73. PubMed ID: 2464744
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of the neu/erb B2 ligand-growth factor from bovine kidney.
Huang SS; Huang JS
J Biol Chem; 1992 Jun; 267(16):11508-12. PubMed ID: 1350785
[TBL] [Abstract][Full Text] [Related]
5. Biochemical comparisons of the normal and oncogenic forms of insect cell-expressed neu tyrosine kinases.
Guy PM; Carraway KL; Cerione RA
J Biol Chem; 1992 Jul; 267(20):13851-6. PubMed ID: 1352772
[TBL] [Abstract][Full Text] [Related]
6. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
Stern DF; Heffernan PA; Weinberg RA
Mol Cell Biol; 1986 May; 6(5):1729-40. PubMed ID: 2878363
[TBL] [Abstract][Full Text] [Related]
7. Downstream signal transduction defects that suppress transformation in two revertant cell lines expressing activated rat neu oncogene.
Reardon DB; Hung MC
J Biol Chem; 1993 Aug; 268(24):18136-42. PubMed ID: 7688739
[TBL] [Abstract][Full Text] [Related]
8. The role of non-ras transforming genes in chemical carcinogenesis.
Cooper CS
Environ Health Perspect; 1991 Jun; 93():33-40. PubMed ID: 1685444
[TBL] [Abstract][Full Text] [Related]
9. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
[TBL] [Abstract][Full Text] [Related]
10. A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.
Lehväslaiho H; Lehtola L; Sistonen L; Alitalo K
EMBO J; 1989 Jan; 8(1):159-66. PubMed ID: 2565807
[TBL] [Abstract][Full Text] [Related]
11. Amplification of the proto-neu oncogene facilitates oncogenic activation by a single point mutation.
Hung MC; Yan DH; Zhao XY
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2545-8. PubMed ID: 2565034
[TBL] [Abstract][Full Text] [Related]
12. Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. Implications for the mechanism of autocrine transformation.
Huang SS; Huang JS
J Biol Chem; 1988 Sep; 263(25):12608-18. PubMed ID: 2842336
[TBL] [Abstract][Full Text] [Related]
13. An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity.
Ben-Levy R; Peles E; Goldman-Michael R; Yarden Y
J Biol Chem; 1992 Aug; 267(24):17304-13. PubMed ID: 1355090
[TBL] [Abstract][Full Text] [Related]
14. Cloning and activation of the Syrian hamster neu proto-oncogene.
Nakamura T; Ushijima T; Ishizaka Y; Nagao M; Arai M; Yamazaki Y; Ishikawa T
Gene; 1994 Mar; 140(2):251-5. PubMed ID: 7908275
[TBL] [Abstract][Full Text] [Related]
15. Transformation of NIH 3T3 cells by overexpression of the normal coding sequence of the rat neu gene.
Di Marco E; Pierce JH; Knicley CL; Di Fiore PP
Mol Cell Biol; 1990 Jun; 10(6):3247-52. PubMed ID: 1971420
[TBL] [Abstract][Full Text] [Related]
16. Carboxyl-terminal deletion and point mutations decrease the transforming potential of the activated rat neu oncogene product.
Mikami Y; Davis JG; Dobashi K; Dougall WC; Myers JN; Brown VI; Greene MI
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7335-9. PubMed ID: 1354355
[TBL] [Abstract][Full Text] [Related]
17. A 25 kDa polypeptide is the ligand for p185neu and is secreted by activated macrophages.
Tarakhovsky A; Zaichuk T; Prassolov V; Butenko ZA
Oncogene; 1991 Dec; 6(12):2187-96. PubMed ID: 1685016
[TBL] [Abstract][Full Text] [Related]
18. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.
Bargmann CI; Hung MC; Weinberg RA
Cell; 1986 Jun; 45(5):649-57. PubMed ID: 2871941
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.
Kraus MH; Fedi P; Starks V; Muraro R; Aaronson SA
Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2900-4. PubMed ID: 8464905
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
